查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1475867

分子診斷試劑市場：依地區：2024-2031年全球產業分析、規模、佔有率、成長、趨勢、預測

Molecular Diagnostics Reagent Market by Geography (North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa): Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2024-2031
出版日期: | 出版商: Persistence Market Research | 英文 258 Pages | 商品交期: 2-5個工作天內

價格
簡介目錄

該研究報告對全球分子診斷試劑市場進行了深入分析。這份綜合報告提供了關鍵市場動態、成長動力、課題和新興趨勢的寶貴見解。它詳細概述了醫療保健行業的分子診斷試劑領域，並提供了獨家數據和統計數據來預測 2024 年至 2031 年的市場成長軌跡。

重要見解

  • 分子診斷試劑市場規模（2024年）：102.5億美元
  • 預計市值（2031年）：140.2億美元
  • 全球市場成長率（2024-2031年複合年增長率）：6.6%

分子診斷試劑市場 - 報告範圍：

分子診斷試劑市場包括用於分子診斷測定的各種試劑、消耗品和檢測試劑盒，用於檢測和分析與疾病和遺傳狀況相關的核酸、蛋白質和其他生物標記。該市場針對臨床實驗室、醫院、診斷中心和研究機構，包括聚合□鏈反應（PCR）、核酸擴增檢測（NAAT）、原位雜交（ISH）和其他分子檢測平台。分子診斷試劑在傳染病診斷、腫瘤檢測、基因篩檢和個人化醫療中發揮重要作用，能夠實現準確及時的診斷、預後預測和治療監測。分子生物學、自動化技術、小型化技術的進步以及對精準醫療和伴隨診斷不斷增長的需求推動了市場成長。

市場驅動因素：

全球分子診斷試劑市場正受益於幾個關鍵的成長促進因素。核酸擴增、定序和檢測方法的技術進步正在徹底改變分子診斷，從而能夠快速、靈敏地檢測病原體、基因突變和疾病相關生物標記。此外，傳染病、癌症和遺傳性疾病的日益普及正在推動對用於疾病篩檢、早期檢測和治療監測的分子診斷試劑的需求。此外，護理點分子檢測平台、數位 PCR 系統和晶片實驗室技術的採用正在擴大不同醫療機構（包括初級保健診所、急診室和資源有限的機構）對分子診斷的使用範圍。此外，新型分子診斷檢測方法和試劑的研發、監管審批和商業化的投資不斷增加，刺激了市場成長和創新。

市場限制因素：

儘管分子診斷試劑市場成長前景廣闊，仍面臨監管監督、報銷政策和市場片段化等課題。圍繞分子診斷測試和試劑的監管環境（包括測定驗證、品質控制和實驗室認證要求）非常複雜，可能會對新進入者和創新技術的市場進入造成障礙。此外，來自醫療保健支付者和保險公司的報銷變化和定價壓力也會影響分子診斷產品和服務的市場推廣和獲利能力。此外，市場分散化以及來自免疫分析、即時檢測和數位健康解決方案等替代診斷技術的競爭為市場整合和差異化帶來了課題。為了解決這些障礙，行業利益相關者、監管機構和醫療保健提供者必須共同努力，簡化監管途徑，建立基於證據的報銷政策，並加速分子診斷技術的採用。

市場機會：

由於技術創新、市場擴張和應用多樣化，分子診斷試劑市場提供了巨大的成長機會。液體活檢、循環腫瘤 DNA (ctDNA) 分析和無細胞核酸檢測等新興趨勢為分子診斷試劑解決癌症診斷、治療監測和微小殘留疾病檢測等未滿足的需求提供了新途徑。人工智慧 (AI)、機器學習 (ML) 和大數據分析的整合實現了分子診斷中數據驅動的決策、預測建模和精準醫學方法。此外，策略合作夥伴關係、研究合作和併購使公司能夠擴大其產品組合、擴大地理覆蓋範圍並利用新的市場趨勢。對創新分子診斷測定和試劑的研發、臨床驗證和商業化的投資對於充分發揮分子診斷在個人化醫療中的潛力至關重要。

本報告解決的關鍵問題

  • 推動全球分子診斷試劑市場成長的因素有哪些？
  • 分子生物學和診斷技術的進步如何改變分子診斷試劑的競爭模式？
  • 分子診斷領域的市場進入者面臨的主要課題和機會是什麼？
  • 哪些疾病領域和診斷應用最有分子診斷試劑成長潛力？
  • 領先公司採取哪些策略來維持市場競爭力並推動創新？

目錄

第一章 全球市場展望

  • 需求側趨勢
  • 供給面趨勢
  • 分析與建議

第二章 市場概況

  • 市場範圍/分類
  • 市場定義/範圍/限制

第 3 章主要市場趨勢

  • 影響市場的主要趨勢
  • 產品創新/發展趨勢

第 4 章 關鍵成功因素

  • 贖回場景
  • 產品映射
  • 監管場景

第五章全球分子診斷試劑市場-價格分析

  • 依產品類型劃分的區域價格分析
  • 價格細目
    • 製造商級定價
    • 經銷商級定價
  • 全球平均價格分析基準

第六章全球分子診斷試劑市場需求（數量與規模）分析

  • 過去的市場價值（金額）分析，2019-2023
  • 當前和未來市場價值（金額）預測，2024-2031
    • 同比增長趨勢分析
    • 絕對回報機會分析

第七章市場背景

  • 宏觀經濟因素
  • 預測變量 - 相關性和影響
  • 價值鏈
  • 市場動態

第八章全球分子診斷試劑市場分析、產品類型

  • 簡介/主要發現
  • 過去的市場規模（金額）和數量分析，2019-2023
  • 目前和未來的市場規模（金額）和定量分析/預測，2024-2031
    • 樣品製備套件
    • PCR檢測試劑盒
    • 原位雜交試劑盒
    • 微陣列晶片試劑盒
    • 定序試劑盒
  • 依產品類型分析市場吸引力

第九章全球分子診斷試劑市場分析（依應用）

  • 簡介/主要發現
  • 過去的市場規模（金額）和數量分析，2019-2023
  • 目前和未來的市場規模（金額）和定量分析/預測，2024-2031
    • 病原體檢測
    • 生物標記篩選
    • 治療監測
    • 其他
  • 應用市場吸引力分析

第十章全球分子診斷試劑最終用戶市場分析

  • 簡介/主要發現
  • 過去的市場規模（金額）和數量分析，2019-2023
  • 目前和未來的市場規模（金額）和定量分析/預測，2024-2031
    • 醫院
    • 研究所
    • 調查機構
    • 生物製藥公司
    • 其他
  • 依最終用途劃分的市場吸引力分析

第十一章全球分子診斷試劑市場分析（依地區）

  • 介紹
  • 過去的市場規模（金額）和數量分析，2019-2023
  • 當前市場規模（金額）和數量分析/預測，2024-2031
    • 北美
    • 拉丁美洲
    • 歐洲
    • 中東和非洲 (MEA)
    • 東亞
    • 南亞
    • 大洋洲
  • 區域市場吸引力分析

第十二章北美分子診斷試劑市場分析

第十三章拉丁美洲分子診斷試劑市場分析

第十四章歐洲分子診斷試劑市場分析

第十五章南亞分子診斷試劑市場分析

第十六章東亞分子診斷試劑市場分析

第十七章 大洋洲分子診斷試劑市場分析

第十八章中東及非洲分子診斷試劑市場分析

第十九章新興國家分子診斷試劑市場分析

  • 全球和國家成長比較
  • 介紹
    • 主要國家市值佔比分析
  • 中國分子診斷試劑市場分析
    • 介紹
    • 依市場類別劃分的市值比率分析
    • 依市場類別分析和預測市場（數量/金額）
      • 產品類別
      • 依最終用途
      • 依申請
    • 中國分子診斷試劑市場-競爭格局
    • 中國貿易分析
  • 印度分子診斷試劑市場分析
    • 介紹
    • 依市場類別劃分的市值比率分析
    • 依市場類別分析和預測市場（數量/金額）
      • 產品類別
      • 依最終用途
      • 依申請
    • 印度分子診斷試劑市場—競爭格局
  • 巴西分子診斷試劑市場分析
    • 介紹
    • 依市場類別劃分的市值比率分析
    • 依市場類別分析和預測市場（數量/金額）
      • 產品類別
      • 依最終用戶
      • 依申請
    • 巴西分子診斷試劑市場－競爭格局

第二十章市場結構分析

  • 依公司層級劃分的市場分析（分子診斷試劑）
  • 市場集中度
  • 主要參與者的市場佔有率分析
  • 市場存在分析

第 21 章 競爭分析

  • 比賽儀表板
  • 競爭價格分析
  • 衝突詳情
    • F. Hoffmann-La Roche Ltd
    • Becton, Dickinson and Company
    • Bio-Rad Laboratories Inc
    • Thermo Fisher Scientific Inc.
    • Merck KGaA
    • Agilent Technologies, Inc.
    • Qiagen NV
    • Illumina, Inc.
    • DiaSorin SpA
    • Hologic Inc.

第 22 章使用的假設和首字母縮略詞

第23章研究方法論

簡介目錄
Product Code: PMRREP27472

Persistence Market Research, a prominent market research firm, has conducted an in-depth analysis of the global Molecular Diagnostics Reagent Market. This comprehensive report offers valuable insights into key market dynamics, growth drivers, challenges, and emerging trends. It provides a detailed overview of the molecular diagnostics reagent segment within the healthcare industry, presenting exclusive data and statistics projecting the market's growth trajectory from 2024 to 2031.

Key Insights:

  • Molecular Diagnostics Reagent Market Size (2024): USD10.25 Bn
  • Projected Market Value (2031): USD14.02 Bn
  • Global Market Growth Rate (CAGR 2024 to 2031): 6.6%

Molecular Diagnostics Reagent Market - Report Scope:

The Molecular Diagnostics Reagent Market encompasses a wide range of reagents, consumables, and test kits used in molecular diagnostic assays for the detection and analysis of nucleic acids, proteins, and other biomarkers associated with diseases and genetic conditions. This market serves clinical laboratories, hospitals, diagnostic centers, and research institutions, offering molecular reagents for polymerase chain reaction (PCR), nucleic acid amplification tests (NAATs), in situ hybridization (ISH), and other molecular testing platforms. Molecular diagnostics reagents play a critical role in infectious disease diagnostics, oncology testing, genetic screening, and personalized medicine, enabling accurate and timely diagnosis, prognosis, and treatment monitoring. Market growth is driven by advancements in molecular biology, automation, and miniaturization technologies, as well as increasing demand for precision medicine and companion diagnostics.

Market Growth Drivers:

The global Molecular Diagnostics Reagent Market benefits from several key growth drivers. Technological advancements in nucleic acid amplification, sequencing, and detection methods have revolutionized molecular diagnostics, enabling rapid and sensitive detection of pathogens, genetic mutations, and biomarkers associated with diseases. Moreover, the growing prevalence of infectious diseases, cancer, and genetic disorders drives demand for molecular diagnostics reagents for disease screening, early detection, and treatment monitoring. Additionally, the adoption of point-of-care molecular testing platforms, digital PCR systems, and lab-on-a-chip technologies expands access to molecular diagnostics in diverse healthcare settings, including primary care clinics, emergency departments, and resource-limited regions. Furthermore, increasing investment in research and development, regulatory approvals, and commercialization of novel molecular diagnostics assays and reagents stimulates market growth and innovation.

Market Restraints:

Despite its promising growth prospects, the Molecular Diagnostics Reagent Market faces challenges related to regulatory oversight, reimbursement policies, and market fragmentation. The complex regulatory landscape governing molecular diagnostics tests and reagents, including assay validation, quality control, and laboratory accreditation requirements, may pose barriers to market entry for new players and innovative technologies. Moreover, variability in reimbursement coverage and pricing pressures from healthcare payers and insurance providers impact market adoption and profitability for molecular diagnostics products and services. Additionally, market fragmentation and competition from alternative diagnostic technologies, such as immunoassays, point-of-care tests, and digital health solutions, create challenges for market consolidation and differentiation. Addressing these barriers requires collaboration between industry stakeholders, regulatory agencies, and healthcare providers to streamline regulatory pathways, establish evidence-based reimbursement policies, and promote technology adoption in molecular diagnostics.

Market Opportunities:

The Molecular Diagnostics Reagent Market presents significant growth opportunities driven by technology innovation, market expansion, and application diversification. Emerging trends such as liquid biopsy, circulating tumor DNA (ctDNA) analysis, and cell-free nucleic acid testing offer new avenues for molecular diagnostics reagents to address unmet needs in cancer diagnostics, treatment monitoring, and minimal residual disease detection. The integration of artificial intelligence (AI), machine learning (ML), and big data analytics enables data-driven decision-making, predictive modeling, and precision medicine approaches in molecular diagnostics. Furthermore, strategic partnerships, collaborations, and mergers and acquisitions enable companies to broaden their product portfolios, expand their geographic reach, and capitalize on emerging market trends. Investments in research and development, clinical validation, and commercialization of innovative molecular diagnostics assays and reagents are essential to harnessing the full potential of molecular diagnostics in personalized healthcare.

Key Questions Answered in the Report:

  • What factors are driving the growth of the Molecular Diagnostics Reagent Market globally?
  • How are advancements in molecular biology and diagnostic technologies reshaping the competitive landscape of molecular diagnostics reagents?
  • What are the key challenges and opportunities facing market participants in the molecular diagnostics segment?
  • Which disease areas and diagnostic applications offer the highest growth potential for molecular diagnostics reagents?
  • What strategies are leading companies employing to maintain their competitive edge and drive innovation in the market?

Competitive Intelligence and Business Strategy:

Leading players in the global Molecular Diagnostics Reagent Market, including biotechnology companies, diagnostic manufacturers, and healthcare suppliers, focus on innovation, product differentiation, and market expansion to gain a competitive edge. These companies invest in research and development to develop novel molecular diagnostics assays, reagents, and test kits tailored to specific disease indications and clinical workflows. Moreover, strategic collaborations with clinical laboratories, academic research institutions, and healthcare providers enable companies to validate product performance, demonstrate clinical utility, and accelerate market adoption. Furthermore, emphasis on customer support, technical training, and scientific education initiatives enhances brand reputation and customer loyalty in the competitive landscape of molecular diagnostics.

Key Companies Profiled:

  • F. Hoffmann-La Roche Ltd
  • Becton, Dickinson and Company
  • Bio-Rad Laboratories Inc
  • Thermo Fisher Scientific Inc.
  • Merck KGaA
  • Agilent Technologies, Inc.
  • Qiagen N.V.
  • Illumina, Inc.
  • DiaSorin S.p.A
  • Hologic Inc.

Molecular Diagnostics Reagent Market Research Segmentation:

Molecular Diagnostics Reagent Market by Product

  • Sample Preparation Kits
  • PCR Assay Kits
  • In situ Hybridization Kits
  • Microarray Kit
  • Sequencing Kit

Molecular Diagnostics Reagent Market by Region

  • North America
  • Latin America
  • Europe
  • Asia Pacific
  • Middle East & Africa (MEA)

Table of Contents

1. Global Market Outlook

  • 1.1. Demand Side Trends
  • 1.2. Supply Side Trends
  • 1.3. Analysis and Recommendations

2. Market Overview

  • 2.1. Market Coverage / Taxonomy
  • 2.2. Market Definition / Scope / Limitations

3. Key Market Trends

  • 3.1. Key Trends Impacting the Market
  • 3.2. Product Innovation / Development Trends

4. Key Success Factors

  • 4.1. Reimbursement Scenario
  • 4.2. Product Mapping
  • 4.3. Regulatory Scenario

5. Global Molecular Diagnostic Reagent Market - Pricing Analysis

  • 5.1. Regional Pricing Analysis By Product Type
  • 5.2. Pricing Break-up
    • 5.2.1. Manufacturer Level Pricing
    • 5.2.2. Distributor Level Pricing
  • 5.3. Global Average Pricing Analysis Benchmark

6. Global Molecular Diagnostic reagent Market Demand (in Value or Size in US$ Mn) Analysis 2019-2023 and Forecast, 2024-2031

  • 6.1. Historical Market Value (US$ Mn) Analysis, 2019-2023
  • 6.2. Current and Future Market Value (US$ Mn) Projections, 2024-2031
    • 6.2.1. Y-o-Y Growth Trend Analysis
    • 6.2.2. Absolute $ Opportunity Analysis

7. Market Background

  • 7.1. Macro-Economic Factors
    • 7.1.1. Global GDP Growth Outlook
    • 7.1.2. Global Internet Penetration Outlook
    • 7.1.3. Global Media and Entertainment Industry Outlook
  • 7.2. Forecast Factors - Relevance & Impact
    • 7.2.1. Top Companies Historical Growth
    • 7.2.2. Global IT Industry Outlook
    • 7.2.3. Global Urbanization Growth Outlook
    • 7.2.4. World Internet User Statistics
    • 7.2.5. Global e-Sports Industry Outlook
  • 7.3. Value Chain
  • 7.4. Market Dynamics
    • 7.4.1. Drivers
    • 7.4.2. Restraints
    • 7.4.3. Opportunity Analysis

8. Global Molecular Diagnostic reagent Market Analysis 2019-2023 and Forecast 2024-2031, by Product Type

  • 8.1. Introduction / Key Findings
  • 8.2. Historical Market Size (US$ Mn) and Volume Analysis By Product Type, 2019-2023
  • 8.3. Current and Future Market Size (US$ Mn) and Volume Analysis and Forecast By Product Type, 2024-2031
    • 8.3.1. Sample Preparation Kits
    • 8.3.2. PCR Assay Kits
    • 8.3.3. In situ Hybridization Kits
    • 8.3.4. Microarray Kit
    • 8.3.5. Sequencing Kit
  • 8.4. Market Attractiveness Analysis By Product Type

9. Global Molecular Diagnostic reagent Market Analysis 2019-2023 and Forecast 2024-2031, by Application

  • 9.1. Introduction / Key Findings
  • 9.2. Historical Market Size (US$ Mn) and Volume Analysis By Application, 2019-2023
  • 9.3. Current and Future Market Size (US$ Mn) and Volume Analysis and Forecast By Application, 2024-2031
    • 9.3.1. Pathogen Detection
    • 9.3.2. Biomarker Screening
    • 9.3.3. Therapeutic Monitoring
    • 9.3.4. Others
  • 9.4. Market Attractiveness Analysis By Application

10. Global Molecular Diagnostic reagent Market Analysis 2019-2023 and Forecast 2024-2031, by End User

  • 10.1. Introduction / Key Findings
  • 10.2. Historical Market Size (US$ Mn) and Volume Analysis By End Use, 2019-2023
  • 10.3. Current and Future Market Size (US$ Mn) and Volume Analysis and Forecast By End Use, 2024-2031
    • 10.3.1. Hospitals
    • 10.3.2. Laboratories
    • 10.3.3. Research Institutes
    • 10.3.4. Biopharmaceutical Companies
    • 10.3.5. Others
  • 10.4. Market Attractiveness Analysis By End Use

11. Global Molecular Diagnostic reagent Market Analysis 2019-2023 and Forecast 2024-2031, by Region

  • 11.1. Introduction
  • 11.2. Historical Market Size (US$ Mn) and Volume Analysis By Region, 2019-2023
  • 11.3. Current Market Size (US$ Mn) and Volume Analysis and Forecast By Region, 2024-2031
    • 11.3.1. North America
    • 11.3.2. Latin America
    • 11.3.3. Europe
    • 11.3.4. Middle East and Africa (MEA)
    • 11.3.5. East Asia
    • 11.3.6. South Asia
    • 11.3.7. Oceania
  • 11.4. Market Attractiveness Analysis By Region

12. North America Molecular Diagnostic reagent Market Analysis 2019-2023 and Forecast 2024-2031

  • 12.1. Introduction
  • 12.2. Pricing Analysis
  • 12.3. Historical Market Size (US$ Mn) and Volume Trend Analysis By Market Taxonomy, 2019-2023
  • 12.4. Market Size (US$ Mn) and Volume Forecast By Market Taxonomy, 2024-2031
    • 12.4.1. By Country
      • 12.4.1.1. U.S.
      • 12.4.1.2. Canada
    • 12.4.2. By Product Type
    • 12.4.3. By Application
    • 12.4.4. By End Use
  • 12.5. Market Attractiveness Analysis
    • 12.5.1. By Country
    • 12.5.2. By Product Type
    • 12.5.3. By Application
    • 12.5.4. By End Use
  • 12.6. Market Trends
  • 12.7. Key Market Participants - Intensity Mapping
  • 12.8. Drivers and Restraints - Impact Analysis

13. Latin America Molecular Diagnostic reagent Market Analysis 2019-2023 and Forecast 2024-2031

  • 13.1. Introduction
  • 13.2. Pricing Analysis
  • 13.3. Historical Market Size (US$ Mn) and Volume Trend Analysis By Market Taxonomy, 2019-2023
  • 13.4. Market Size (US$ Mn) and Volume Forecast By Market Taxonomy, 2024-2031
    • 13.4.1. By Country
      • 13.4.1.1. Brazil
      • 13.4.1.2. Mexico
      • 13.4.1.3. Rest of Latin America
    • 13.4.2. By Product Type
    • 13.4.3. By Application
    • 13.4.4. By End Use
  • 13.5. Market Attractiveness Analysis
    • 13.5.1. By Country
    • 13.5.2. By Product Type
    • 13.5.3. By Application
    • 13.5.4. By End User
  • 13.6. Market Trends
  • 13.7. Key Market Participants - Intensity Mapping
  • 13.8. Drivers and Restraints - Impact Analysis

14. Europe Molecular Diagnostic reagent Market Analysis 2019-2023 and Forecast 2024-2031

  • 14.1. Introduction
  • 14.2. Pricing Analysis
  • 14.3. Historical Market Size (US$ Mn) and Volume Trend Analysis By Market Taxonomy, 2019-2023
  • 14.4. Market Size (US$ Mn) and Volume Forecast By Market Taxonomy, 2024-2031
    • 14.4.1. By Country
      • 14.4.1.1. Germany
      • 14.4.1.2. Italy
      • 14.4.1.3. France
      • 14.4.1.4. U.K.
      • 14.4.1.5. Spain
      • 14.4.1.6. BENELUX
      • 14.4.1.7. Russia
      • 14.4.1.8. Rest of Europe
    • 14.4.2. By Product Type
    • 14.4.3. By Application
    • 14.4.4. By End Use
  • 14.5. Market Attractiveness Analysis
    • 14.5.1. By Country
    • 14.5.2. By Product Type
    • 14.5.3. By Application
    • 14.5.4. By End User
  • 14.6. Market Trends
  • 14.7. Key Market Participants - Intensity Mapping
  • 14.8. Drivers and Restraints - Impact Analysis

15. South Asia Molecular Diagnostic reagent Market Analysis 2019-2023 and Forecast 2024-2031

  • 15.1. Introduction
  • 15.2. Pricing Analysis
  • 15.3. Historical Market Size (US$ Mn) and Volume Trend Analysis By Market Taxonomy, 2019-2023
  • 15.4. Market Size (US$ Mn) and Volume Forecast By Market Taxonomy, 2024-2031
    • 15.4.1. By Country
      • 15.4.1.1. India
      • 15.4.1.2. Thailand
      • 15.4.1.3. Indonesia
      • 15.4.1.4. Malaysia
      • 15.4.1.5. Rest of South Asia
    • 15.4.2. By Product Type
    • 15.4.3. By Application
    • 15.4.4. By End User
  • 15.5. Market Attractiveness Analysis
    • 15.5.1. By Country
    • 15.5.2. By Product Type
    • 15.5.3. By Application
    • 15.5.4. By End User
  • 15.6. Market Trends
  • 15.7. Key Market Participants - Intensity Mapping
  • 15.8. 15.8.Drivers and Restraints - Impact Analysis

16. East Asia Molecular Diagnostic reagent Market Analysis 2019-2023 and Forecast 2024-2031

  • 16.1. Introduction
  • 16.2. Pricing Analysis
  • 16.3. Historical Market Size (US$ Mn) and Volume Trend Analysis By Market Taxonomy, 2019-2023
  • 16.4. Market Size (US$ Mn) and Volume Forecast By Market Taxonomy, 2024-2031
    • 16.4.1. By Country
      • 16.4.1.1. China
      • 16.4.1.2. Japan
      • 16.4.1.3. South Korea
    • 16.4.2. By Product Type
    • 16.4.3. By Application
    • 16.4.4. By End Use
  • 16.5. Market Attractiveness Analysis
    • 16.5.1. By Country
    • 16.5.2. By Product Type
    • 16.5.3. By Application
    • 16.5.4. By End User
  • 16.6. Market Trends
  • 16.7. Key Market Participants - Intensity Mapping
  • 16.8. Drivers and Restraints - Impact Analysis

17. Oceania Molecular Diagnostic reagent Market Analysis 2019-2023 and Forecast 2024-2031

  • 17.1. Introduction
  • 17.2. Pricing Analysis
  • 17.3. Historical Market Size (US$ Mn) and Volume Trend Analysis By Market Taxonomy, 2019-2023
  • 17.4. Market Size (US$ Mn) and Volume Forecast By Market Taxonomy, 2024-2031
    • 17.4.1. By Country
      • 17.4.1.1. Australia
      • 17.4.1.2. New Zealand
    • 17.4.2. By Product Type
    • 17.4.3. By Application
    • 17.4.4. By End User
  • 17.5. Market Attractiveness Analysis
    • 17.5.1. By Country
    • 17.5.2. By Product Type
    • 17.5.3. By Application
    • 17.5.4. By End User
  • 17.6. Market Trends
  • 17.7. Key Market Participants - Intensity Mapping
  • 17.8. Drivers and Restraints - Impact Analysis

18. Middle East and Africa Molecular Diagnostic reagent Market Analysis 2019-2023 and Forecast 2024-2031

  • 18.1. Introduction
  • 18.2. Pricing Analysis
  • 18.3. Historical Market Size (US$ Mn) and Volume Trend Analysis By Market Taxonomy, 2019-2023
  • 18.4. Market Size (US$ Mn) and Volume Forecast By Market Taxonomy, 2024-2031
    • 18.4.1. By Country
      • 18.4.1.1. GCC Countries
      • 18.4.1.2. Northern Africa
      • 18.4.1.3. South Africa
      • 18.4.1.4. Rest of Middle East and Africa
    • 18.4.2. By Product Type
    • 18.4.3. By Application
    • 18.4.4. By End Use
  • 18.5. Market Attractiveness Analysis
    • 18.5.1. By Country
    • 18.5.2. By Product Type
    • 18.5.3. By Application
    • 18.5.4. By End User
  • 18.6. Market Trends
  • 18.7. Key Market Participants - Intensity Mapping
  • 18.8. Drivers and Restraints - Impact Analysis

19. Emerging Countries Molecular Diagnostic reagent Market Analysis 2019-2023 and Forecast 2024-2031

  • 19.1. Global Vs. Country Growth Comparison
  • 19.2. Introduction
    • 19.2.1. Market Value Proportion Analysis, By Key Countries
  • 19.3. China Molecular Diagnostic reagent Market Analysis
    • 19.3.1. Introduction
    • 19.3.2. Market Value Proportion Analysis by Market Taxonomy
    • 19.3.3. Market Volume (Mn Units) and Value (US$ Mn) Analysis and Forecast by Market Taxonomy
      • 19.3.3.1. By Product Type
      • 19.3.3.2. By End Use
      • 19.3.3.3. By Application
    • 19.3.4. China Molecular Diagnostic reagent Market - Competition Landscape
    • 19.3.5. China - Trade Analysis
  • 19.4. India Molecular Diagnostic reagent Market Analysis
    • 19.4.1. Introduction
    • 19.4.2. Market Value Proportion Analysis by Market Taxonomy
    • 19.4.3. Market Volume (Mn Units) and Value (US$ Mn) Analysis and Forecast by Market Taxonomy
      • 19.4.3.1. By Product Type
      • 19.4.3.2. By End Use
      • 19.4.3.3. By Application
    • 19.4.4. India Molecular Diagnostic reagent Market - Competition Landscape
  • 19.5. Brazil Molecular Diagnostic reagent Market Analysis
    • 19.5.1. Introduction
    • 19.5.2. Market Value Proportion Analysis by Market Taxonomy
    • 19.5.3. Market Volume (Mn Units) and Value (US$ Mn) Analysis and Forecast by Market Taxonomy
      • 19.5.3.1. By Product Type
      • 19.5.3.2. By End User
      • 19.5.3.3. By Application
    • 19.5.4. Brazil Molecular Diagnostic reagent Market - Competition Landscape

20. Market Structure Analysis

  • 20.1. Market Analysis by Tier of Companies (Molecular Diagnostic reagents)
  • 20.2. Market Concentration
  • 20.3. Market Share Analysis of Top Players
  • 20.4. Market Presence Analysis
    • 20.4.1. By Regional footprint of Players
    • 20.4.2. Product foot print by Players
    • 20.4.3. Channel Foot Print by Players

21. Competition Analysis

  • 21.1. Competition Dashboard
  • 21.2. Pricing Analysis by Competition
  • 21.3. Competition Deep Dive
    • 21.3.1. F. Hoffmann-La Roche Ltd
      • 21.3.1.1. Overview
      • 21.3.1.2. Product Portfolio
      • 21.3.1.3. Profitability by Market Segments (Product/Channel/Region)
      • 21.3.1.4. Sales Footprint
      • 21.3.1.5. Strategy Overview
        • 21.3.1.5.1. Marketing Strategy
        • 21.3.1.5.2. Product Strategy
        • 21.3.1.5.3. Channel Strategy
    • 21.3.2. Becton, Dickinson and Company
      • 21.3.2.1. Overview
      • 21.3.2.2. Product Portfolio
      • 21.3.2.3. Profitability by Market Segments (Product/Channel/Region)
      • 21.3.2.4. Sales Footprint
      • 21.3.2.5. Strategy Overview
        • 21.3.2.5.1. Marketing Strategy
        • 21.3.2.5.2. Product Strategy
        • 21.3.2.5.3. Channel Strategy
    • 21.3.3. Bio-Rad Laboratories Inc
      • 21.3.3.1. Overview
      • 21.3.3.2. Product Portfolio
      • 21.3.3.3. Profitability by Market Segments (Product/Channel/Region)
      • 21.3.3.4. Sales Footprint
      • 21.3.3.5. Strategy Overview
        • 21.3.3.5.1. Marketing Strategy
        • 21.3.3.5.2. Product Strategy
        • 21.3.3.5.3. Channel Strategy
    • 21.3.4. Thermo Fisher Scientific Inc.
      • 21.3.4.1. Overview
      • 21.3.4.2. Product Portfolio
      • 21.3.4.3. Profitability by Market Segments (Product/Channel/Region)
      • 21.3.4.4. Sales Footprint
      • 21.3.4.5. Strategy Overview
        • 21.3.4.5.1. Marketing Strategy
        • 21.3.4.5.2. Product Strategy
        • 21.3.4.5.3. Channel Strategy
    • 21.3.5. Merck KGaA
      • 21.3.5.1. Overview
      • 21.3.5.2. Product Portfolio
      • 21.3.5.3. Profitability by Market Segments (Product/Channel/Region)
      • 21.3.5.4. Sales Footprint
      • 21.3.5.5. Strategy Overview
        • 21.3.5.5.1. Marketing Strategy
        • 21.3.5.5.2. Product Strategy
        • 21.3.5.5.3. Channel Strategy
    • 21.3.6. Agilent Technologies, Inc.
      • 21.3.6.1. Overview
      • 21.3.6.2. Product Portfolio
      • 21.3.6.3. Profitability by Market Segments (Product/Channel/Region)
      • 21.3.6.4. Sales Footprint
      • 21.3.6.5. Strategy Overview
        • 21.3.6.5.1. Marketing Strategy
        • 21.3.6.5.2. Product Strategy
        • 21.3.6.5.3. Channel Strategy
    • 21.3.7. Qiagen N.V.
      • 21.3.7.1. Overview
      • 21.3.7.2. Product Portfolio
      • 21.3.7.3. Profitability by Market Segments (Product/Channel/Region)
      • 21.3.7.4. Sales Footprint
      • 21.3.7.5. Strategy Overview
        • 21.3.7.5.1. Marketing Strategy
        • 21.3.7.5.2. Product Strategy
        • 21.3.7.5.3. Channel Strategy
    • 21.3.8. Illumina, Inc.
      • 21.3.8.1. Overview
      • 21.3.8.2. Product Portfolio
      • 21.3.8.3. Profitability by Market Segments (Product/Channel/Region)
      • 21.3.8.4. Sales Footprint
      • 21.3.8.5. Strategy Overview
        • 21.3.8.5.1. Marketing Strategy
        • 21.3.8.5.2. Product Strategy
        • 21.3.8.5.3. Channel Strategy
    • 21.3.9. DiaSorin S.p.A
      • 21.3.9.1. Overview
      • 21.3.9.2. Product Portfolio
      • 21.3.9.3. Profitability by Market Segments (Product/Channel/Region)
      • 21.3.9.4. Sales Footprint
      • 21.3.9.5. Strategy Overview
        • 21.3.9.5.1. Marketing Strategy
        • 21.3.9.5.2. Product Strategy
        • 21.3.9.5.3. Channel Strategy
    • 21.3.10. Hologic Inc.
      • 21.3.10.1. Overview
      • 21.3.10.2. Product Portfolio
      • 21.3.10.3. Profitability by Market Segments (Product/Channel/Region)
      • 21.3.10.4. Sales Footprint
      • 21.3.10.5. Strategy Overview
        • 21.3.10.5.1. Marketing Strategy
        • 21.3.10.5.2. Product Strategy
        • 21.3.10.5.3. Channel Strategy

22. Assumptions and Acronyms Used

23. Research Methodology